International French-speaking multicentre practice survey on hepatic hydrothorax (HH) : Results of the "Hep Hep" study among 529 hepatogastroenterologist (HG) or pneumologist (PN) respondents.

J. Cadranel (Creil, France), C. Jacques (Paris, France), I. Ollivier (Caen, France), T. Thevenot (Besançon, France), E. Nguyen-Khac (Amiens, France), C. Bureau (Toulouse, France), M. Allaire (Tours, France), J. Nousbaum (Brest, France), V. Loustaud-Ratti ( Limoges, France), X. Causse (Orléan, France), P. Sogni (Paris, France), B. Hanslik (Montpellier, France), M. Bourlière (Marseille, France), J. Péron (Toulouse, France), N. Ganne-Carrié (Bobigny, France), T. Dao (Caen, France), B. Maitre (Créteil, France), L. Elkrief (Tours, France), C. Raherison (Bordeaux, France), T. Le Magoarou (Creil, France)

Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Session: What's new in respiratory problems in rare and systemic diseases
Session type: E-poster
Number: 3303

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Cadranel (Creil, France), C. Jacques (Paris, France), I. Ollivier (Caen, France), T. Thevenot (Besançon, France), E. Nguyen-Khac (Amiens, France), C. Bureau (Toulouse, France), M. Allaire (Tours, France), J. Nousbaum (Brest, France), V. Loustaud-Ratti ( Limoges, France), X. Causse (Orléan, France), P. Sogni (Paris, France), B. Hanslik (Montpellier, France), M. Bourlière (Marseille, France), J. Péron (Toulouse, France), N. Ganne-Carrié (Bobigny, France), T. Dao (Caen, France), B. Maitre (Créteil, France), L. Elkrief (Tours, France), C. Raherison (Bordeaux, France), T. Le Magoarou (Creil, France). International French-speaking multicentre practice survey on hepatic hydrothorax (HH) : Results of the "Hep Hep" study among 529 hepatogastroenterologist (HG) or pneumologist (PN) respondents.. 3303

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus
Source: ERJ Open Res, 7 (1) 00529-2020; 10.1183/23120541.00529-2020
Year: 2021



Study of 793 COPD patients treated by general practitioners (GPs), intensivists (IPs) and pulmonologists (Ps) across India
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008


Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study).
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Applying telemonitoring (TMon) post-admission for COPD, at scale: Preliminary findings from a large European trial
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016


Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


COPD in primary care - international survey DSP III (patient population description)
Source: Eur Respir J 2004; 24: Suppl. 48, 90s
Year: 2004

A review of in-house Video Observed Therapy (VOT) for patients with active tuberculosis(TB), in a  London teaching hospital.
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018




Critical review of the current management of pleural infection in a UK district general hospital. Applying the MIST II (multicentre intrapleural sepsis trial) evidence to our current practice
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


More than 50% of patients visit a general practitioner (GP), general physician (Gen P) or a pediatrician (P) in India for respiratory symptoms: Results of a one-day point-prevalence study in 2,04,912 patients across 22 states and 5 union territories in India
Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care
Year: 2012

Healthcare professionals (HCPs) attitudes towards referring patients to pulmonary rehabilitation (PR); a cross sectional exploratory survey
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017


Assessment of senior medical students in the field of bronchial asthma. Final results of the study ASSA (2014-2016)
Source: International Congress 2019 – Medical education
Year: 2019


The Wessex AsThma CoHort (WATCH) difficult asthma study; integrating research into the clinic
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016


Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Clinical outcomes of patients with HAP/VAP due to PVL(+) vs. PVL(-) MRSA: Results from the IMPACT-HAP study
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Characteristics of patients meeting the new definition of pulmonary hypertension (Nice 2018) in single Japanese PH center.
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019

Management of children and young people (CYP) in London with asthma: a clinical  audit report.
Source: International Congress 2018 – Primary care management of asthma
Year: 2018

Anti-tobacco medical advice (amb): differencial study between pneumology (pn)vs. primary care (PC)
Source: Eur Respir J 2003; 22: Suppl. 45, 28s
Year: 2003

Real-world effects of tezacaftor/ivacaftor (TEZ/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021


Real-world effects of lumacaftor/ivacaftor (LUM/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021